CeGaT Expands Genetic Testing Services to U.S. and Canada, Partnering with Major InsurersMay 22, 2024|
CeGaT and Twist Bioscience Launch RNA Fusion Panel to Advance Oncology and Precision Medicine ResearchJune 1, 2023|
CeGaT Is One of the First Companies Worldwide to Receive the Most Powerful Sequencing Platform NovaSeq™ X PlusMarch 14, 2023|
Illumina NovaSeq™ X: CeGaT is One of the First Companies to Order Illumina’s Brand New SequencerSeptember 29, 2022|
